T1	PROC 232 254	retirada de medicación
T2	CHEM 66 76	etanercept
#1	AnnotatorNotes T2	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T3	PROC 80 91	monoterapia
#2	AnnotatorNotes T3	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T4	CHEM 101 112	metotrexato
#3	AnnotatorNotes T4	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T5	PROC 116 127	monoterapia
#4	AnnotatorNotes T5	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T6	DISO 180 199	artritis reumatoide
#5	AnnotatorNotes T6	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T7	PROC 256 281	aleatorizado, doble ciego
T8	CHEM 244 254	medicación
#6	AnnotatorNotes T8	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T9	CHEM 301 311	etanercept
#7	AnnotatorNotes T9	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T10	PROC 315 326	monoterapia
#8	AnnotatorNotes T10	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T11	CHEM 336 347	metotrexato
#9	AnnotatorNotes T11	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T12	PROC 351 362	monoterapia
#10	AnnotatorNotes T12	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T13	DISO 415 434	artritis reumatoide
#11	AnnotatorNotes T13	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T14	DISO 457 476	Artritis reumatoide
#12	AnnotatorNotes T14	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T15	DISO 535 545	enfermedad
#13	AnnotatorNotes T15	C0012634; Disease; Disease or Syndrome
T16	DISO 549 551	AR
#14	AnnotatorNotes T16	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T17	PROC 603 614	tratamiento
#15	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	DISO 638 640	AR
#16	AnnotatorNotes T18	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T19	PROC 701 712	tratamiento
#17	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	CHEM 747 758	metotrexato
#18	AnnotatorNotes T20	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T21	CHEM 824 835	metotrexato
#19	AnnotatorNotes T21	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T22	PROC 941 950	protocolo
#20	AnnotatorNotes T22	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T23	DISO 1062 1082	hepatitis alcohólica
#21	AnnotatorNotes T23	C0019187; Hepatitis, Alcoholic; Disease or Syndrome
T24	DISO 1084 1114	esteatohepatitis no alcohólica
#22	AnnotatorNotes T24	C3241937; Nonalcoholic Steatohepatitis; Disease or Syndrome
T25	DISO 1117 1147	síndromes de inmunodeficiencia
#23	AnnotatorNotes T25	C0021051; Immunologic Deficiency Syndromes; Disease or Syndrome
T26	DISO 1161 1214	infección por el Virus de la Inmunodeficiencia Humana
T27	DISO 1248 1257	infección
#24	AnnotatorNotes T27	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T28	DISO 1276 1296	infecciones crónicas
#25	AnnotatorNotes T28	C0151317; Chronic Infection; Disease or Syndrome
T29	CHEM 1343 1366	agentes antiinfecciosos
#26	AnnotatorNotes T29	C0003204; Anti-Infective Agents; Pharmacologic Substance
T30	DISO 1453 1462	infección
#27	AnnotatorNotes T30	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T31	PROC 1505 1520	hospitalización
#28	AnnotatorNotes T31	C0019993; Hospitalization; Health Care Activity
T32	CHEM 1523 1546	agentes antiinfecciosos
#29	AnnotatorNotes T32	C0003204; Anti-Infective Agents; Pharmacologic Substance
T33	DISO 1647 1691	adicción o dependencia conocidas del alcohol
T34	CHEM 1800 1804	FAME
#30	AnnotatorNotes T34	C0242708; Antirheumatic Drugs, Disease-Modifying; Pharmacologic Substance
T35	DISO 1741 1770	consumo o abuso de sustancias
T36	CHEM 1817 1827	etanercept
#31	AnnotatorNotes T36	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T37	CHEM 1846 1879	inhibidor oral de la cinasa Janus
T38	DISO 1956 1982	enfermedades concomitantes
#32	AnnotatorNotes T38	C0243087; concomitant disease; Pathologic Function
T39	PROC 2040 2049	protocolo
#33	AnnotatorNotes T39	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T40	CHEM 619 629	etanercept
#34	AnnotatorNotes T40	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T41	Observation 1693 1708	consume alcohol
T42	Date 12 16	2014
T43	LIVB 168 175	sujetos
#35	AnnotatorNotes T43	C0681850; Study Subject; Group
T45	LIVB 403 410	sujetos
#36	AnnotatorNotes T45	C0681850; Study Subject; Group
T46	Duration 560 569	≥ 6 meses
T47	LIVB 585 597	investigador
#37	AnnotatorNotes T47	C0035173; Research Personnel; Professional or Occupational Group
T48	Duration 649 658	≥ 6 meses
T49	Dose 717 743	una dosis de 10 mg a 25 mg
T51	Frequency 759 778	una vez a la semana
T52	Duration 787 796	≥ 6 meses
T53	Dose 803 820	una dosis estable
T54	Route 836 840	oral
#38	AnnotatorNotes T54	C1527415; Oral Route of Drug administration; Functional Concept
T55	Duration 849 860	≥ 8 semanas
T56	Age 901 910	≥ 18 años
T58	LIVB 1023 1029	sujeto
#39	AnnotatorNotes T58	C0681850; Study Subject; Group
T60	LIVB 1178 1214	Virus de la Inmunodeficiencia Humana
#40	AnnotatorNotes T60	C0019682; HIV; Virus
T61	LIVB 1221 1227	sujeto
#41	AnnotatorNotes T61	C0681850; Study Subject; Group
T62	Duration 1288 1296	crónicas
#42	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	Duration 1375 1388	las 4 semanas
T64	LIVB 1433 1439	sujeto
#43	AnnotatorNotes T64	C0681850; Study Subject; Group
T65	Route 1547 1559	intravenosos
#44	AnnotatorNotes T65	C1522726; Intravenous Route of Drug Administration; Functional Concept
T66	Duration 1569 1582	las 8 semanas
T67	LIVB 1627 1633	sujeto
#45	AnnotatorNotes T67	C0681850; Study Subject; Group
T68	Frequency 1709 1717	a diario
T69	Date 1726 1737	actualmente
T70	LIVB 1777 1783	sujeto
#46	AnnotatorNotes T70	C0681850; Study Subject; Group
T71	Route 1856 1860	oral
#47	AnnotatorNotes T71	C1527415; Oral Route of Drug administration; Functional Concept
T72	Duration 1880 1889	≤ 6 meses
T73	LIVB 1933 1939	sujeto
#48	AnnotatorNotes T73	C0681850; Study Subject; Group
T74	LIVB 2020 2032	investigador
#49	AnnotatorNotes T74	C0035173; Research Personnel; Professional or Occupational Group
T44	Neg_cue 1805 1816	distinto de
T50	Quantifier_or_Qualifier 678 695	de preinclusión 1
T57	PROC 671 677	visita
#50	AnnotatorNotes T57	C1512346; Patient Visit; Health Care Activity
T59	Quantifier_or_Qualifier 880 897	de preinclusión 1
T75	PROC 873 879	visita
#51	AnnotatorNotes T75	C1512346; Patient Visit; Health Care Activity
T76	Quantifier_or_Qualifier 1409 1426	de preinclusión 1
T77	PROC 1402 1408	visita
#52	AnnotatorNotes T77	C1512346; Patient Visit; Health Care Activity
T78	Quantifier_or_Qualifier 1603 1620	de preinclusión 1
T79	PROC 1596 1602	visita
#53	AnnotatorNotes T79	C1512346; Patient Visit; Health Care Activity
T80	PROC 1902 1908	visita
#54	AnnotatorNotes T80	C1512346; Patient Visit; Health Care Activity
T81	Quantifier_or_Qualifier 1909 1926	de preinclusión 1
A1	Status T23 History_of
A2	Status T24 History_of
A3	Status T25 History_of
A4	Status T26 History_of
A5	Status T27 History_of
A6	Status T28 History_of
A7	Assertion T36 Negated
A8	Status T34 History_of
A9	Status T37 History_of
#55	AnnotatorNotes T7	C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#56	AnnotatorNotes T1	C0850893; stop medication; Therapeutic or Preventive Procedure
#57	AnnotatorNotes T26	C0019693; HIV Infections; Disease or Syndrome
#58	AnnotatorNotes T69	C0521116; Current (present time); Temporal Concept 
T82	Neg_cue 1101 1103	no
T83	Food 1104 1114	alcohólica
A10	Assertion T83 Negated
#59	AnnotatorNotes T83	C0001967; Alcoholic Beverages; Food
T84	Food 1072 1082	alcohólica
#60	AnnotatorNotes T84	C0001967; Alcoholic Beverages; Food
T85	Food 1701 1708	alcohol
#61	AnnotatorNotes T85	C0001967; Alcoholic Beverages; Food
R1	Used_for Arg1:T2 Arg2:T3	
R2	Used_for Arg1:T4 Arg2:T5	
T86	Observation 156 164	remisión
R3	Experiences Arg1:T43 Arg2:T86	
#62	AnnotatorNotes T86	C0544452; Disease remission; Finding
R4	Experiences Arg1:T43 Arg2:T2	
R5	Experiences Arg1:T43 Arg2:T4	
R6	Experiences Arg1:T43 Arg2:T6	
R7	Before Arg1:T6 Arg2:T86	
R8	Used_for Arg1:T8 Arg2:T1	
R9	Used_for Arg1:T9 Arg2:T10	
R10	Used_for Arg1:T11 Arg2:T12	
T87	Observation 391 399	remisión
#63	AnnotatorNotes T87	C0544452; Disease remission; Finding
R11	Before Arg1:T13 Arg2:T87	
R12	Experiences Arg1:T45 Arg2:T1	
R13	Experiences Arg1:T45 Arg2:T9	
R14	Experiences Arg1:T45 Arg2:T11	
R15	Experiences Arg1:T45 Arg2:T87	
R16	Experiences Arg1:T45 Arg2:T13	
T88	Observation 521 545	control de la enfermedad
#64	AnnotatorNotes T88	C2911690; Disease Controlled; Finding
T89	Quantifier_or_Qualifier 512 520	muy buen
R17	Has_Quantifier_or_Qualifier Arg1:T88 Arg2:T89	
R18	Has_Duration_or_Interval Arg1:T88 Arg2:T46	
R19	Used_for Arg1:T40 Arg2:T17	
R20	Has_Duration_or_Interval Arg1:T40 Arg2:T48	
R21	Before Arg1:T17 Arg2:T57	
R22	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T50	
R23	Used_for Arg1:T20 Arg2:T19	
R24	Has_Dose_or_Strength Arg1:T20 Arg2:T49	
R25	Has_Frequency Arg1:T20 Arg2:T51	
R26	Has_Duration_or_Interval Arg1:T20 Arg2:T52	
R27	Has_Dose_or_Strength Arg1:T21 Arg2:T53	
R28	Has_Route_or_Mode Arg1:T21 Arg2:T54	
R29	Has_Duration_or_Interval Arg1:T21 Arg2:T55	
R30	Before Arg1:T21 Arg2:T75	
R31	Has_Quantifier_or_Qualifier Arg1:T75 Arg2:T59	
R32	Used_for Arg1:T21 Arg2:T19	
T90	PROC 925 934	selección
#65	AnnotatorNotes T90	C0242802; Patient Selection; Research Activity
R33	Overlap Arg1:T90 Arg2:T56	
R34	Experiences Arg1:T58 Arg2:T23	
R35	Causes Arg1:T84 Arg2:T23	
R36	Causes Arg1:T83 Arg2:T24	
R37	Experiences Arg1:T58 Arg2:T24	
R38	Experiences Arg1:T58 Arg2:T25	
R39	Experiences Arg1:T58 Arg2:T26	
R40	Causes Arg1:T60 Arg2:T26	
R41	Negation Arg1:T82 Arg2:T83	
R42	Experiences Arg1:T61 Arg2:T27	
R43	Experiences Arg1:T61 Arg2:T28	
R44	Has_Duration_or_Interval Arg1:T28 Arg2:T62	
T91	Quantifier_or_Qualifier 1258 1264	activa
#66	AnnotatorNotes T91	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R45	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T91	
T92	Quantifier_or_Qualifier 1299 1310	localizadas
#67	AnnotatorNotes T92	C0392752; Localized; Spatial Concept
R46	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T92	
R47	Experiences Arg1:T61 Arg2:T29	
R48	Has_Duration_or_Interval Arg1:T29 Arg2:T63	
R49	Before Arg1:T29 Arg2:T77	
R50	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T76	
R51	Experiences Arg1:T64 Arg2:T30	
R52	Experiences Arg1:T64 Arg2:T31	
R53	Experiences Arg1:T64 Arg2:T32	
R54	Has_Route_or_Mode Arg1:T32 Arg2:T65	
R55	Has_Duration_or_Interval Arg1:T32 Arg2:T66	
R56	Before Arg1:T32 Arg2:T79	
R57	Has_Quantifier_or_Qualifier Arg1:T79 Arg2:T78	
T93	Quantifier_or_Qualifier 1463 1468	grave
#68	AnnotatorNotes T93	C1547227; Severe - Severity of Illness Code; Intellectual Product
R58	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T93	
R59	Experiences Arg1:T67 Arg2:T33	
T94	Food 1684 1691	alcohol
#69	AnnotatorNotes T94	C0001967; Alcoholic Beverages; Food
R60	Causes Arg1:T94 Arg2:T33	
R61	Experiences Arg1:T70 Arg2:T34	
R62	Negation Arg1:T44 Arg2:T36	
R63	Experiences Arg1:T70 Arg2:T37	
R64	Has_Route_or_Mode Arg1:T37 Arg2:T71	
R65	Has_Duration_or_Interval Arg1:T37 Arg2:T72	
R66	Before Arg1:T37 Arg2:T80	
R67	Before Arg1:T34 Arg2:T80	
R68	Has_Quantifier_or_Qualifier Arg1:T80 Arg2:T81	
#70	AnnotatorNotes T37	C3854325; Janus kinase inhibitor; Pharmacologic Substance (?) | C3854326; Janus Kinase Inhibitor [EPC]; Pharmacologic Substance
R69	Experiences Arg1:T73 Arg2:T38	
T95	Quantifier_or_Qualifier 1946 1955	una o más
R70	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T95	
T96	Quantifier_or_Qualifier 1983 1997	significativas
#71	AnnotatorNotes T96	C1546944; Event Seriousness - Significant; Qualitative Concept
R71	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T96	
R72	Experiences Arg1:T67 Arg2:T41	
#72	AnnotatorNotes T41	C4273278; alcohol use behavior; Finding | C5428797; finding of alcohol drinking behavior; Finding
R73	Has_Frequency Arg1:T41 Arg2:T68	
R74	Overlap Arg1:T35 Arg2:T69	
R75	Experiences Arg1:T67 Arg2:T35	
#73	AnnotatorNotes T35	C0740858; Substance abuse problem; Mental or Behavioral Dysfunction
#74	AnnotatorNotes T33	C2106524; combined drug and alcohol abuse; Mental or Behavioral Dysfunction | C2919052; Alcohol or other drugs dependence; Mental or Behavioral Dysfunction
#75	AnnotatorNotes T89	C3641222; Very good (qualifier value); Qualitative Concept 
R76	Experiences Arg1:T67 Arg2:T94	
R77	Experiences Arg1:T67 Arg2:T85	
R78	Experiences Arg1:T58 Arg2:T84	
R79	Experiences Arg1:T58 Arg2:T83	
A11	Experiencer T43 Patient
A12	Experiencer T45 Patient
A13	Experiencer T47 Other
A14	Experiencer T58 Patient
A15	Experiencer T61 Patient
A16	Experiencer T64 Patient
A17	Experiencer T67 Patient
A18	Experiencer T70 Patient
A19	Experiencer T73 Patient
A20	Experiencer T74 Other
